• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
EUM
Click for more information
0.00% 8.0¢

EUMERALLA RESOURCES LIMITED

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
EUM
News: EUM Ausmex Mining Group says non-executive chairman David Wheeler resigns 		02/08/17 0 249
02/08/17 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  249 
EUM
Ann: Ausmex Exercises Cloncurry Option 		10/05/17 0 544
10/05/17 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  544 
EUM
Ann: Appendix 3B 		09/05/17 0 424
09/05/17 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  424 
EUM
Ann: Completion of Ausmex Transaction and Change of Name 		09/05/17 0 425
09/05/17 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  425 
EUM
News: EUM Eumeralla Resources appoints Matthew Morgan as managing director 		09/05/17 0 414
09/05/17 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  414 
EUM
Ann: Quarterly Activities Report 		28/04/17 0 288
28/04/17 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  288 
EUM
Ann: Quarterly Cashflow Report 		28/04/17 0 308
28/04/17 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  308 
EUM
Ann: Supplementary Prospectus 		21/04/17 0 236
21/04/17 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  236 

See All Discussions arrow Created with Sketch.

Top Stories

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks Copper prices slump; Trump Wall Street rally fades; US health stocks dip on RFK appointment – and much more.
CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch CuFe Ltd (ASX:CUF) has decided not to wait around for Northern Star's Crossroads mine to get up and running, selling its $4M royalty right.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.